Work

Supplementary File 1 from Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance

Year: 2023

Type: supplementary-materials

Abstract: Supplemental File 1: Differential Gene Expression between drug naive versus resistant/"recovery" U87 cell line

DOI: 10.1158/1541-7786.22514067.v1

Authors: Esther P. Jane, Daniel R. Premkumar, Swetha Thambireddy, Brian Golbourn, Sameer Agnihotri, Kelsey C. Bertrand, Stephen C. Mack, Max I. Myers, Ansuman Chattopadhyay, D. Lansing Taylor, Mark E. Schurdak, Andrew M. Stern, Ian F. Pollack

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362536210

Cites:

Cited by:

Related to: 10